Zag Bio

Series-A
zagbio.com Biotech & Healthcare Cambridge, United States
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Undisclosed
Investors 10 Backers
Decision Makers 3 Verified

About Zag Bio

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Cambridge, United States
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website zagbio.com
Domain Registered Date Sep 30, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    zagbio.com

Investors & Backers

10
AbbVie
Boxer Capital
JDRF T1D Fund
KdT Ventures
Lightspeed
Mission BioCapital
Pear VC
Polaris
Regeneron Ventures
Sanofi Ventures

Funding History

1 Round
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

5

Alan Crane

Co-Founder and Board Chair

Work email & phone locked Unlock →

Diane Mathis

Founder

Work email & phone locked Unlock →

Jason Cole

CEO

Work email & phone locked Unlock →

John D. Kulman

Co-Founder

Work email & phone locked Unlock →

Jo Viney

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts